Kos Seeks Court Order to Block Launch of Generic Niaspan
By Marius Meland · March 9, 2005, 12:00 AM EST
Kos Pharmaceuticals has filed a lawsuit to block Barr Pharmaceuticals from launching generic versions of Kos' cholesterol-lowering drug Niaspan upon the expiration of a 30-month stay of approval by the U.S....
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login